register

News & Trends - Biotechnology

CSL Chief Scientific Officer elected as Fellow of Australian Academy of Science for outstanding contribution

Health Industry Hub | May 27, 2020 |

Professor Andrew Cuthbertson, Chief Scientific Officer and Director of CSL is among a group of Australian scientists being acknowledged for their outstanding contributions to science.

Professor Cuthbertson is one of 24 scientists elected as a Fellow of the Australian Academy of Science. He was thrilled to join such a distinguished group with scientific excellence as their guiding principle.

Australian Academy of Science President, Professor John Shine AC, congratulated the new Fellows for making significant and lasting impacts in their scientific disciplines.

“These scientists were elected by their Academy peers following a rigorous evaluation process,” said Professor Shine.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Women make up 42% of this year’s new Fellows.

“The number of women in this year’s elected Fellows reflects the Academy’s work to apply best practice in our nomination and election processes.

“We encourage the STEM sector to continue to nurture diversity in all its forms, so that the STEM workforce reflects the composition of our society,” Professor Shine said.

Over the past five years, 34% of the Fellows elected have been women. Following this year’s election, the Fellowship stands at 559 Fellows, 90 of whom are women.

In alignment with the Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to support Pharma, Biotech and MedTech industry professionals. The initiative is supported by Medicines Australia, AusBiotech, MTAA and ARCS Australia. Learn more.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.